packageTocilizumab

tocilizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tocilizumab, a monoclonal antibody that blocks interleukin signalling, is used to treat rheumatoid and juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, and COVID-19. It is authorised in the European Union and widely used for these inflammatory conditions.

Summary written by glm-5.3-flash from Wikidata Q425154 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tocilizumab
ATC codes:L04AC07
DrugBank:DB06273
Wikidata:Q425154
molar mass:148000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown